Garland Mary, Hsu Fang-Chi, Shen Perry, Clark Clancy J
Am Surg. 2017 Aug 1;83(8):860-865.
The newly characterized modified frailty index (mFI) is a robust predictor of postoperative outcomes for surgical patients. The present study investigates the optimal cutoff for mFI specifically in older gastrointestinal (GI) cancer patients undergoing surgery. All patients more than 60 years old who underwent surgery for a GI malignancy (esophagus, stomach, colon, rectum, pancreas, liver, and bile duct) were identified in the 2005 to 2012 National Surgical Quality Improvement Program, Participant Use Data File (NSQIP PUF). Patients undergoing emergency procedures, of American Society of Anesthesiologists (ASA) five status, or diagnosed with preoperative sepsis were excluded. Logistic regression modeling and 10-fold cross validation were used to identify an optimal mFI cutoff. A total of 41,455 patients (mean age 72, 47.4% female) met the eligibility criteria. Among them, 19.0 per cent (n = 7891) developed a major postoperative complication and 2.8 per cent (n = 1150) died within 30 days. A random sampling by a cancer site was performed to create 90 per cent training and 10 per cent test sample datasets. Using 10-fold cross validation, logistical regression models evaluated the association between mFI and endpoints of 30-day mortality and major morbidity at various cutoffs. Optimal cutoffs for 30-day mortality and major morbidity were mFI ≥ 0.1 and ≥0.2, respectively. After adjusting for age, sex, ASA, albumin ≥3g/dl, and body mass index ≥ 30 kg/m2, mFI ≥ 0.1 was associated with increased mortality (odds ratio (OR) 1.49, 1.30-1.71 95% confidence interval (CI), P < 0.001) and mFI ≥ 0.2 was associated with increased morbidity (OR 1.52, 1.39-1.65 95% CI, P < 0.001). For older GI cancer patients, a very low mFI was a predictor of poor postoperative outcomes with an optimal cutoff of two or more mFI characteristics.
新确定的改良衰弱指数(mFI)是手术患者术后结局的有力预测指标。本研究专门调查了mFI在接受手术的老年胃肠道(GI)癌症患者中的最佳临界值。在2005年至2012年国家外科质量改进计划参与者使用数据文件(NSQIP PUF)中,确定了所有60岁以上因胃肠道恶性肿瘤(食管、胃、结肠、直肠、胰腺、肝脏和胆管)接受手术的患者。排除接受急诊手术、美国麻醉医师协会(ASA)五级状态或术前诊断为败血症的患者。采用逻辑回归建模和10折交叉验证来确定mFI的最佳临界值。共有41455名患者(平均年龄72岁,47.4%为女性)符合纳入标准。其中,19.0%(n = 7891)发生了严重术后并发症,2.8%(n = 1150)在30天内死亡。通过癌症部位进行随机抽样,以创建90%的训练样本数据集和10%的测试样本数据集。使用10折交叉验证,逻辑回归模型评估了不同临界值下mFI与30天死亡率和严重并发症终点之间的关联。30天死亡率和严重并发症的最佳临界值分别为mFI≥0.1和≥0.2。在调整年龄、性别、ASA、白蛋白≥3g/dl和体重指数≥30kg/m2后,mFI≥0.1与死亡率增加相关(比值比(OR)1.49,95%置信区间(CI)1.30 - 1.71,P < 0.001),mFI≥0.2与并发症增加相关(OR 1.52,95%CI 1.39 - 1.65,P < 0.001)。对于老年胃肠道癌症患者,mFI极低是术后结局不良的预测指标,最佳临界值为两个或更多mFI特征。